Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases

被引：139

作者：

Bodaghi, Ali ^{[1
]}

Fattahi, Nadia ^{[2
,3
]}

Ramazani, Ali ^{[2
,4
]}

机构：

[1] Islamic Azad Univ, Dept Chem, Tuyserkan Branch, Tuyserkan, Iran

[2] Univ Zanjan, Dept Chem, Zanjan 4537138791, Iran

[3] Trita Nanomed Res & Technol Dev Ctr TNRTC, Zanjan Hlth Technol Pk, Zanjan 4515613191, Iran

[4] Univ Zanjan, Res Inst Modern Biol Tech RIMBT, Dept Biotechnol, Zanjan 4537138791, Iran

来源：

HELIYON | 2023年 / 9卷 / 02期

关键词：

Biomarker; Diagnosis; Diseases; Covid-19; Cancer; Imaging; Treatment; SQUARES DISCRIMINANT-ANALYSIS; BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; PATTERN-RECOGNITION; CANCER; PROTEOMICS; DISCOVERY; GENOMICS; PROTEIN; IDENTIFICATION;

D O I：

10.1016/j.heliyon.2023.e13323

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The use of biomarkers as early warning systems in the evaluation of disease risk has increased markedly in the last decade. Biomarkers are indicators of typical biological processes, pathogenic processes, or pharmacological reactions to therapy. The application and identification of bio-markers in the medical and clinical fields have an enormous impact on society. In this review, we discuss the history, various definitions, classifications, characteristics, and discovery of bio-markers. Furthermore, the potential application of biomarkers in the diagnosis, prognosis, and treatment of various diseases over the last decade are reviewed. The present review aims to inspire readers to explore new avenues in biomarker research and development.

引用

页数：18

共 192 条

[1] A novel approach based on combining deep learning models with statistical methods for COVID-19 time series forecasting [J].

Abbasimehr, Hossein ;

Paki, Reza ;

Bahrini, Aram .

NEURAL COMPUTING & APPLICATIONS, 2022, 34 (04) :3135-3149

[2] Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review [J].

Aboughdir, Maryam ;

Kirwin, Thomas ;

Khader, Ashiq Abdul ;

Wang, Brian .

VIRUSES-BASEL, 2020, 12 (05)

[3] Biofluid biomarkers of traumatic brain injury [J].

Agoston, Denes V. ;

Shutes-David, Andrew ;

Peskind, Elaine R. .

BRAIN INJURY, 2017, 31 (09) :1195-1203

[4] Mass spectrometry for glycan biomarker discovery [J].

Aizpurua-Olaizola, O. ;

Sastre Torano, J. ;

Falcon-Perez, J. M. ;

Williams, C. ;

Reichardt, N. ;

Boons, G. -J. .

TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2018, 100 :7-14

[5] The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva [J].

Amann, Anton ;

Costello, Ben de Lacy ;

Miekisch, Wolfram ;

Schubert, Jochen ;

Buszewski, Boguslaw ;

Pleil, Joachim ;

Ratcliffe, Norman ;

Risby, Terence .

JOURNAL OF BREATH RESEARCH, 2014, 8 (03)

[6] Proteome and proteomics: New technologies, new concepts, and new words [J].

Anderson, NL ;

Anderson, NG .

ELECTROPHORESIS, 1998, 19 (11) :1853-1861

[7] Serum bone biomarkers osteocalcin and pyridinoline in mares during pregnancy and lactation, and in foals during early post-natal life [J].

Anderson, Stephen T. ;

Kidd, Lisa J. ;

Barton, Anita J. ;

Greer, Ristan M. .

RESEARCH IN VETERINARY SCIENCE, 2018, 118 :34-40

[8] Biomarker-guided trials: Challenges in practice [J].

Antoniou, M. ;

Kolamunnage-Dona, R. ;

Wason, J. ;

Bathia, R. ;

Billingham, C. ;

Bliss, J. M. ;

Brown, L. C. ;

Gillman, A. ;

Paul, J. ;

Jorgensen, A. L. .

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 16

[9]

Aronson Jeffrey K, 2017, Curr Protoc Pharmacol, V76, DOI 10.1002/cpph.19

[10] Biomarkers and surrogate endpoints [J].

Aronson, JK .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) :491-494

← 1 2 3 4 5 6 7 8 9 10 →